Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic ...
An FDA advisory panel concluded clinical data for a Capricor treatment for Duchenne muscular dystrophy did not provide ...
Patients, advocates, and experts fear the difficulty in documenting a frailty exemption to Medicaid work requirements will ...
Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. BOSTON — In an order issued Thursday, a federal judge denied 26 ...
The White House decision to end a Medicare drug subsidy plays into Democratic arguments ahead of the midterms.
The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says misled ...
Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market ...
While politicians call for Fauci to be jailed, STAT’s Adam Feuerstein has an extensive follow-up story on biotech’s ...
You might recall that in mid-June, there was a Nature Medicine study that pitted clinical AI systems OpenEvidence and ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
The authors were among the writers of a recent Council on Foreign Relations report on U.S. biopharma dependence on China. First Opinion is STAT’s platform for interesting, illuminating, and ...
At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions about ...